Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 23 von 30
American journal of medical genetics, 2004-04, Vol.126A (3), p.248-252
2004
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
UBE3A gene mutations in finnish Angelman syndrome patients detected by conformation sensitive gel electrophoresis
Ist Teil von
  • American journal of medical genetics, 2004-04, Vol.126A (3), p.248-252
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2004
Quelle
Wiley Online Library - AutoHoldings Journals
Beschreibungen/Notizen
  • Angelman syndrome (AS) is a neurogenetic disorder associated with a loss of maternal gene expression in chromosome region 15q11‐q13 due to either maternal deletion, paternal uniparental disomy (UPD), imprinting mutation, or mutation in the UBE3A gene. UBE3A encodes an ubiquitin‐protein ligase and shows brain‐specific imprinting. We have done conformation sensitive gel electrophoresis (CSGE) mutation analysis of the UBE3A coding region in nine AS patients, who had shown a normal biparental inheritance and methylation pattern of the 15q11‐q13. Disease‐causing mutations were identified in five of them: three deletions (1930delAG, 3093delAAGA) and two missense mutations (902A → C, 975T → C). Both deletions have also been detected in other AS patients, suggesting these sites may be prone to deletions in the UBE3A gene. All AS cases were sporadic, but a mosaicism for mutation 902A → C was present in a patient's mother. Screening for the UBE3A mutations in the AS patients was found useful both for the confirmation of diagnosis and genetic counseling. CSGE was found to be a sensitive and simple screening method for these mutations. © 2003 Wiley‐Liss, Inc.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX